Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115118706 | 11511870 | 6 | F | 20151026 | 20160630 | 20150916 | 20160701 | EXP | CO-ROCHE-1634518 | ROCHE | 60.82 | YR | F | Y | 50.00000 | KG | 20160701 | CN | CO | CO |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115118706 | 11511870 | 1 | PS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 103792 | 416 | MG | SOLUTION FOR INFUSION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
115118706 | 11511870 | 1 | Breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
115118706 | 11511870 | HO |
115118706 | 11511870 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
115118706 | 11511870 | Arthralgia | |
115118706 | 11511870 | Decreased appetite | |
115118706 | 11511870 | Dehydration | |
115118706 | 11511870 | Malaise | |
115118706 | 11511870 | Myalgia | |
115118706 | 11511870 | Rash | |
115118706 | 11511870 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
115118706 | 11511870 | 1 | 20150410 | 0 |